µ¿¼ºÁ¦¾à(´ëÇ¥ÀÌ»ç À̾籸)Àº Áö³ 14ÀÏ Á¦11ȸ ¼ÛÀ½ À̼±±Ô ÀÇ ¾àÇлó ¼ö»óÀÚ¸¦ ¼±Á¤ ¹ßÇ¥Çß´Ù. ¿ÃÇØ 11ȸ° ¼ö»óÀÚ´Â ±¹³»ÀÇ ¿À¿ìÅñ³¼ö¿Í ¹Ì±¹ÀÇ Åä´Ï À¯ ¹Ú»ç·Î ¼±Á¤Çß´Ù
¿À¿ìÅà ±³¼ö´Â ´Ù¾çÇÑ »ý¸®ÇÐÀûÀÎ È°¼º¿¡ °ü¿©ÇÏ´Â chloride channelÀÇ ºÐÀÚ»ý¹°ÇÐÀû ¿¬±¸¸¦ ÅëÇØ ÇâÈÄ ¾àÇа迡 Å©°Ô ±â¿©ÇÒ °ÍÀ¸·Î ±â´ëµÇ´Â ÇÐÀÚ·Î °¢±¤¹Þ°í ÀÖÀ¸¸ç ¾à 11°³ÀÇ ±¹³»·¿ÜÀÇ Æ¯Çã¿Í ÇØ¿Ü Àú³Î 67Æí, ±¹³» 15Æí µîÀÇ È°¹ßÇÑ Çмú È°µ¿À» ÇÏ°í ÀÖ´Ù
Åä´Ï À¯ ¹Ú»ç´Â SemisolidÀÇ dosage form ¹× ÈíÀÔ Aerosol µî¿¡ ¸¹Àº ¿¬±¸¸¦ ÇÏ¿´À¸¸ç ƯÈ÷ È÷·çµòÀ» µ¶ÀÚÀûÀÎ À¯ÀüÀÚ ÀçÁ¶ÇÕÀ» ÅëÇؼ Á¦Ç°È½ÃŲ µ¥½Ã·çµòÀº Ç×ÀÀ°í ½ÃÀå¿¡¼ ȹ±âÀûÀÎ Àα⸦ ¾òÀ» °ÍÀ¸·Î Àü¸ÁÇÏ°í ÀÖÀ¸¸ç, ¾à 30¿©ÆíÀÇ ³í¹®°ú 5±ÇÀÇ Àú¼, 7°³ÀÇ Æ¯Ç㸦 º¸À¯ÇÏ°í ÀÖ´Ù
ÇöÀç ¿À¿ìÅà ±³¼ö´Â ¼¿ï´ëÇб³ ¾àÇдëÇп¡ ±³¼ö·Î ÀçÁ÷ ÁßÀ̸ç Åä´Ï À¯ ¹Ú»ç´Â Canyon Pharmaceuticals¸¦ ¼³¸³ÇÏ¿© »çÀåÀ¸·Î ÀçÁ÷ ÁßÀÌ´Ù.
µ¿¼ºÁ¦¾àÀÇ Ã¢¾÷ÀÚÀÎ ¼ÛÀ½ À̼±±ÔȸÀåÀÌ ±â¾÷ÀÌÀ±À» »çȸ¿¡ ȯ¿ø½ÃÅ°°íÀÚ 1998³â Á¦1ȸ
·Î ½ÃÀÛÇÏ¿© ¿ÃÇØ·Î 11ȸ° ½Ã»óÀ» ÇÏ°Ô µÇ¾úÀ¸¸ç ¼ö»óÀÚ 2¸í¿¡°Ô °¢°¢ 1õ¸¸¿øÀÇ »ó±ÝÀ» ¼ö¿©ÇÑ´Ù (Á¦4ȸºÎÅÍ´Â ¿Ü±¹ÀÎ Æ÷ÇÔ)
¼ö»óÀÚ ¼±Á¤ ½É»çÀ§¿øȸ´Â ¹Ú¸¸±â(¼¿ï´ë¾àÇÐ´ë ¸í¿¹±³¼ö)½É»çÀ§¿øÀå ¿Ü À§¿ø 2Àΰú µ¿¼ºÁ¦¾à ±è¿¬¼ö ºÎȸÀåÀ¸·Î ±¸¼ºÇÏ¿© ¾öÁ¤ÇÑ ½É»ç¸¦ ÅëÇØ ¿¬±¸¾÷ÀûÀÌ ¶Ù¾î³ª°í ¿ì¸®³ª¶ó »Ó ¾Æ´Ï¶ó ¼¼°è ¾àÇйßÀüÀ» À§ÇÑ ¹ÙÅÁ À§¿¡ ÀÌ·ç¾îÁø °ÍÀÎÁö¿¡ ´ëÇÑ °ËÅä·Î ¼±Á¤µÇ¾ú´Ù
½Ã»ó½ÄÀº ¿À´Â 11¿ù 25ÀÏ(È¿äÀÏ) ¿ÀÈÄ 6½Ã °³²±¸³íÇöµ¿ ÀÓÇǸ®¾ó ÆÓ¸®½ºÈ£ÅÚ(7Ãþ) µÎº£È¦¿¡¼ ½Ã»ó½ÄÀ» °¡Áú ¿¹Á¤ÀÌ´Ù
¿À¿ìÅà ±³¼ö(¼¿ï´ëÇб³ ¾àÇдëÇÐ)ÇÁ·ÎÇÊ
¿À¿ìÅà ±³¼ö´Â ¼¿ï´ëÇб³ ¾àÇдëÇп¡¼ Çлç, ¼®»ç¸¦ ¸¶Ä¡°í ¹Ì±¹ ¿ÀŬ¶óÈ£¸¶´ëÇб³ ÀÇ °ú´ëÇп¡¼ »ý¸®ÇÐ Àü°øÀ¸·Î ÀÌÇйڻç ÇÐÀ§¸¦ ÃëµæÇÏ°í ÇöÀç ¼¿ï´ë ¾à´ë ±³¼ö·Î ÀçÁ÷ ÁßÀÌ ´Ù Àú¼·Î´Â The Current Topics in Membranes°¡ ÀÖÀ¸¸ç ¾à 11°³ÀÇ ±¹³»·¿ÜÀÇ Æ¯Çã¿Í ÇØ¿Ü Àú³Î 67Æí, ±¹³» 15Æí µîÀÇ È°¹ßÇÑ Çмú È°µ¿À» ÇÏ°í ÀÖ´Ù
1974~1978 ¼¿ï´ëÇб³ ¾àÇдëÇÐ, Çлç
1980~1982 ¼¿ï´ëÇб³ ¾àÇдëÇпø, ¼®»ç
1983~1987 ¿ÀŬ¶óÈ£¸¶´ëÇб³ ÀÇ°ú´ëÇÐ »ý¸®ÇÐ ¹Ú»ç
(³í¹®: Effects of Urinary Bladder Distension on Activity of T1~T5 Spinal
and Raphe-spinal Neurons)
1988~1993 ¼¿ï´ëÇб³ ¾àÇдëÇÐ Á¶±³¼ö
1993~1999 ¼¿ï´ëÇб³ ¾àÇдëÇÐ ºÎ±³¼ö
1999~ÇöÀç ¼¿ï´ëÇб³ ¾àÇдëÇÐ ±³¼ö
[ÁÖ¿ä ¿¬±¸³»¿ë ¹× ¾÷Àû]
NatureÁö¿¡ article·Î ¹ßÇ¥µÈ ‘TMEM16A confers receptor-activated calcium-dependent
chloride conductance’Àº ´Ù¾çÇÑ »ý¸®ÇÐÀûÀÎ È°¼º¿¡ °ü¿©ÇÏ´Â chloride channelÀÇ ºÐÀÚ»ý
¹°ÇÐÀû ¿¬±¸¸¦ ÅëÇØ ÇâÈÄ ¾àÇа迡 Å©°Ô ±â¿©ÇÒ °ÍÀ¸·Î ±â´ëµÇ´Â ÇÐÀÚ·Î °¢±¤¹Þ°í ÀÖ´Ù
[ÁÖ¿ä ¼ö»ó °æ·Â]
1997 Á¦ 7ȸ °úÇбâ¼ú ¿ì¼ö³í¹®»ó
2005 ³²¾ç ¾Ë·Î¿¡ »ý¸í¾àÇÐ Çмú»ó
2005 ƯÇã±â¼ú»ó ¼¼Á¾´ë¿Õ»ó
2006 ´ëÇѹα¹Çмú¿ø»ó
¹Ì±¹ Åä´Ï À¯ ¹Ú»ç(CHENG-DER(TONY) YU, PH.D.) ÇÁ·ÎÇÊ
Åä´Ï À¯ ¹Ú»çÀº ±¹¸³Å¸ÀÌ¿Ï´ëÇп¡¼ ¾àÇÐÀ» Àü°øÇÏ¿´À¸¸ç ¹Ì±¹ ¹Ì½Ã°£ÁÖ Wayne State
University¿¡¼ ¾àÇ°ÈÇÐÀ¸·Î ¹Ú»ç ÇÐÀ§¸¦ ¹Þ¾Ò´Ù
Ç÷θ®´Ù ´ëÇп¡¼ Pharm D. Ãëµæ ÈÄ 25³â¿© °£ ÇöÀå¿¡¼ ±â¼ú °ü¸®¸¦ ´ã´çÇÏ¿´À¸¸ç Çö
Àç Canyon PharmaceuticalsÀ» ¼³¸³ÇÏ¿© »çÀåÀ¸·Î ÀçÁ÷ ÁßÀÌ´Ù
Àú¼·Î´Â Polyoxyethylene Castor oil À¯µµÃ¼ ¿Ü 5±Ç, ƯÇã·Î´Â ¾àÀÇ ÇǺÎÈí¼ö Áõ°Á¦
¹× ¹æ¹ý ¿Ü 7°³, Çмú ³í¹®ÀÌ 30ÆíÀÌ ÀÖ´Ù.
National Taiwan University, Taipei, Taiwan: B.S.- Pharmacy
Wayne State University, Detroit, Michigan: M.S. - Pharmaceutical
Chemistry
University of Michigan, Ann Arbor, Michigan: Ph. D. - Pharmaceutical
Chemistry
University of Florida, Gainesville, Florida: Pharm. D.
1978~1985 SYNTEX(now Roche): Senior staff Researcher
1985~1988 Cooper Laboratories: Manager, Pharmaceutical Development
1994~1999 State University of New York, Department of Pharmaceutics
1988~1999 Basic Pharmaceutics and Stability Groups, PRI: Associate
Director
1988~2002 BRISTOL-MYERS SQUIBB, PRI: Research Fellow
2002~2003: UPM Pharmaceuticals, INC: Vice President
2003~ÇöÀç Canyon Pharmaceuticals: °øµ¿¼³¸³ÀÚ, »çÀå
[ÁÖ¿ä ¿¬±¸ ¹× ¾÷Àû]
SemisolidÀÇ dosage form ¹× ÈíÀÔ Aerosol µî¿¡ ¸¹Àº ¿¬±¸¸¦ ÇÏ¿´À¸¸ç ƯÈ÷ È÷·çµòÀ» µ¶ÀÚÀûÀÎ À¯ÀüÀÚ ÀçÁ¶ÇÕÀ» ÅëÇؼ Á¦Ç°È½ÃŲ µ¥½Ã·çµòÀº Ç×ÀÀ°í ½ÃÀå¿¡¼ ȹ±âÀûÀÎ Àα⸦ ¾òÀ» °ÍÀ¸·Î Àü¸ÁÇÏ°í ÀÖÀ¸¸ç, ¾à 30¿©ÆíÀÇ ³í¹®°ú 5±ÇÀÇ Àú¼, 7°³ÀÇ Æ¯Ç㸦 º¸À¯ÇÏ°í ÀÖ´Ù
[ÁÖ¿ä ¼ö»ó °æ·Â]
1.1996: President’s Award from BRISTOL-MYERS SQUIBB
2.1985: Science Award from SYNTEX
3.1981: Ebert Prize Award from the American Pharmaceutical Association for best publication